We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

204 hedge funds and large institutions have $1B invested in Immunogen Inc in 2022 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 68 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more call options, than puts

Call options by funds: $6.78M | Put options by funds: $3.42M

6% more capital invested

Capital invested by funds: $948M → $1B (+$55.2M)

1% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 68

8% less funds holding

Funds holding: 222 → 204 (-18)

39% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 44

Holders
204
Holders Change
-18
Holders Change %
-8.11%
% of All Funds
3.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
69
Reduced
68
Closed
44
Calls
$6.78M
Puts
$3.42M
Net Calls
+$3.35M
Net Calls Change
-$1.16M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$27.3M
2
MC
Maverick Capital
Texas
+$18M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$17.5M
4
Jennison Associates
Jennison Associates
New York
+$16M
5
State Street
State Street
Massachusetts
+$15.8M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$40M
2
ClearBridge Investments
ClearBridge Investments
New York
-$23.1M
3
Renaissance Technologies
Renaissance Technologies
New York
-$8.15M
4
Citadel Advisors
Citadel Advisors
Florida
-$7.67M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$6.76M
Name Holding Trade Value Shares
Change 		Change in
Stake
EGM
226
Engineers Gate Manager
New York
– -$98K -20,526 Closed
BAM
227
Blueshift Asset Management
New Jersey
– -$89K -18,616 Closed
VRS
228
Virginia Retirement Systems
Virginia
– -$77K -16,100 Closed
KAS
229
Kestra Advisory Services
Texas
– -$75K -15,787 Closed
AT
230
Arden Trust
Delaware
– -$70K -14,657 Closed
YIH
231
Y-Intercept (HK)
Hong Kong
– -$68.5K -14,325 Closed
QT
232
Quantamental Technologies
New York
– -$62K -12,959 Closed
AI
233
Atom Investors
Texas
– -$62K -12,929 Closed
SEC
234
Seven Eight Capital
New York
– -$60K -12,632 Closed
SIG
235
Stonegate Investment Group
Alabama
– -$57K -11,867 Closed
NW
236
NewEdge Wealth
Pennsylvania
– -$53K -11,088 Closed
SI
237
Stephens Inc
Arkansas
– -$52K -10,780 Closed
WTA
238
Washington Trust Advisors
Massachusetts
– -$11K -2,217 Closed
WWMSC
239
Wagner Wealth Management (South Carolina)
South Carolina
– -$10K -2,100 Closed
Macquarie Group
240
Macquarie Group
Australia
– -$25K -1,834 Closed
WWM
241
Wolff Wiese Magana
California
– -$9K -1,825 Closed
IFAM
242
Institutional & Family Asset Management
Colorado
– -$3K -667 Closed
WTC
243
WhitTier Trust Company
Nevada
– -$3K -626 Closed
HNWAG
244
High Net Worth Advisory Group
Florida
– -$2K -500 Closed
QC
245
Quent Capital
New York
– -$1K -187 Closed
C
246
Covestor
United Kingdom
– -$76 -14 -37%
6 7 8 9
10

IMGN Hedge Fund Activity: Q4 2022 in Review

204 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2022, worth a combined $1B — up 5.8% from $948M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of IMGN and 27 opened new positions — a net loss of 17 holders — while 68 trimmed existing stakes and 69 added.

The largest buyer was Woodline Partners, opening a new position worth an estimated $27.3M. The largest seller was Deerfield Management, cutting an estimated $40M.

  • 204 institutional investors held Immunogen Inc (IMGN) as of Q4 2022, down from 222 in Q3 2022.
  • Funds reported $1B of Immunogen Inc stock for Q4 2022, up 5.8% quarter-over-quarter.
  • 27 funds opened new Immunogen Inc positions in Q4 2022 and 44 closed out, a net change of -17 holders.
  • The largest Immunogen Inc buyer in Q4 2022 was Woodline Partners, an estimated $27.3M added.
  • The largest Immunogen Inc seller in Q4 2022 was Deerfield Management, an estimated $40M sold.

Based on aggregated 13F filings for Q4 2022.